ARCHIVES

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI.

May 19, 2006

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

American Cancer Society Awards its Medal of Honor

May 24, 2013

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center

July 18, 1997

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012